Treatments for Neuropathy
OwnerGabriel Corfas, Joshua C. Murtieinventors
Life of this patent
Estimating the term…
Abstract
Small fiber neuropathy is treated or prevented by topically administering to a subject in need thereof topically active quinoline compounds or pharmaceutically acceptable salts thereof under conditions effective to treat or prevent neuropathy in the subject. Glial cell-derived neurotrophic factor (GDNF) receptors are modulated with the subject active quinoline compounds, which may be formulated in topical lotions.
Claims13
1-20. (canceled)
A method of treating a small fiber peripheral neuropathy in a person determined to be in need thereof comprising:
- topically administering to the person an anti-peripheral neuropathic quinoline compound of the formula:
- wherein R1-R7 are each independently H, hydroxy, halogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted arylalkyl, substituted or unsubstituted amine, substituted or unsubstituted alkylamine, substituted or unsubstituted dialkylamine, substituted or unsubstituted alkoxy, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted alkoxy, substituted or unsubstituted haloalkyl,
- or a pharmaceutically acceptable salt thereof.
A method of treating a small fiber peripheral neuropathy in a person determined to be in need thereof comprising:
- topically administering to the person an agonist of glial cell-derived neurotrophic factor (GDNF) receptor GFRα1 or GFRα2, under conditions effective to treat the peripheral neuropathy in the person.
A topical lotion comprising an anti-peripheral neuropathic effective amount of an anti-peripheral neuropathic quinoline compound having a formula/name of Table 1, Table 2 Table 3, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier formulated for topical application.
Dependencies are inferred from the claim text.